Tag Archives: telehealth

Feds warn hospitals not to divulge patients’ telehealth information – Scripps News

  1. Feds warn hospitals not to divulge patients’ telehealth information Scripps News
  2. FTC, HHS warn providers about privacy risks of tracking tech FierceHealthcare
  3. FTC, OCR caution hospitals and telehealth providers against using online tracking International Association of Privacy Professionals
  4. OCR and FTC Issue Joint Statement Warning Health Care Providers and App Developers About Use of Third Party Online Tracking Technologies Mintz
  5. FTC, OCR send warning letter to hospitals about online tracking pixels Healthcare IT News
  6. View Full Coverage on Google News

Read original article here

FTC and HHS Warn Hospital Systems and Telehealth Providers about Privacy and Security Risks from Online Tracking Technologies – Federal Trade Commission News

  1. FTC and HHS Warn Hospital Systems and Telehealth Providers about Privacy and Security Risks from Online Tracking Technologies Federal Trade Commission News
  2. HIPAA violations a risk with tracking pixels, FTC, HHS warn Modern Healthcare
  3. Changing Landscape: Federal and State Regulators Focus on Protecting Consumer Health Data Foley & Lardner LLP
  4. HHS Office for Civil Rights and the Federal Trade Commission Warn Hospital Systems and Telehealth Providers about Privacy and Security Risks from Online Tracking Technologies HHS.gov
  5. FTC-HHS joint letter gets to the heart of the risks tracking technologies pose to personal health information Federal Trade Commission News
  6. View Full Coverage on Google News

Read original article here

Increased use of telehealth services and medications for opioid use disorder during the COVID-19 pandemic associated with reduced risk for fatal overdose – nih.gov

  1. Increased use of telehealth services and medications for opioid use disorder during the COVID-19 pandemic associated with reduced risk for fatal overdose nih.gov
  2. Telehealth Services Tied to a Major Reduction in Overdose Deaths Medscape
  3. Used After Opioid Overdose, Anti-Addiction Drug Can Cut Odds for Fatal OD U.S. News & World Report
  4. Buprenorphine initiation in the ER found safe and effective for individuals with opioid use disorder who use fentanyl nih.gov
  5. Increased Use of Telehealth Services and Medications for Opioid Use Disorder During the COVID-19 Pandemic Associated with Reduced Risk for Fatal Overdose | CDC Online Newsroom CDC
  6. View Full Coverage on Google News

Read original article here

Meta’s stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market – MarketWatch

  1. Meta’s stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market MarketWatch
  2. Stocks making the biggest premarket moves: Meta, Rivian, WW International, KeyCorp and more CNBC
  3. 5 stocks to watch on Tuesday: Meta Platforms, Rivian and more (NASDAQ:META) Seeking Alpha
  4. Meta, Dick’s Sporting Goods and WW International rise premarket; Rivian falls By Investing.com Investing.com
  5. Stocks making the biggest moves midday: Rivian, Delta, Snap, Dish Network and more CNBC
  6. View Full Coverage on Google News

Read original article here

MIT’s 10 breakthrough technologies for 2023: Abortion pills via telehealth and engineered organs

Engineered organs that could end transplant waiting lists, abortion pills on demand and mass-marketing military drones that will revolutionize warfare are among those listed on MIT Technology Review’s 10 Breakthrough Technologies of 2023.

The list also includes the use of CRISPR to edit away people’s problems with high cholesterol by rewriting a sliver of their DNA, artificial intelligence that makes artwork and NASA’s James Webb Space Telescope, which is set to remodel our knowledge of the cosmos. 

The 22nd annual list features critical technological advances predicted to change how we live and work fundamentally. 

MIT Technology Review, owned by the Massachusetts Institute of Technology, compiled the list of companies or institutions set to develop breakthroughs and when the public can expect these innovations.

MIT Technology Review announced its 10 Breakthrough Technologies of 2023, which are advanced technologies predicted to change our lives

Mat Honan, editor-in-chief of MIT Technology Review, said: ‘Our breakthrough technologies lists are fascinating snapshots of the evolution of big tech innovation breakthroughs. 

‘They document the progress we have made in many of the core areas at the intersection of science and engineering. Inclusion is not an endorsement as much as it is a statement about the potential impact of a technology. 

‘Some of my favorite picks on the list this year are the ones that inspire a sense of awe and wonder at the scope of human achievement.’

CRISPR for high cholesterol: Editing genes to save lives

The list includes the use of CRISPR to edit away people’s problems with high cholesterol by rewriting a sliver of their DNA. In July 2022, a patient in New Zealand received a gene-editing medicine (pictured) that permanently lowered her cholesterol

Artificial intelligence is a major technology and is being used to create stunning pieces of artwork

WHO: Verve Therapeutics, Beam Therapeutics, Prime Medicine, Broad Institute 

WHEN: 10 to 15 years

In July 2022, a patient in New Zealand received a gene-editing medicine that permanently lowered her cholesterol.

The move led to a trial among 40 individuals from the UK and the US, who are now testing ‘Verve-101.’

The cholesterol-lowering treatment, developed by Verve Therapeutics, relies on a form of gene editing called base editing, or ‘CRISPR 2.0.’ 

Verve-101 deletes a tiny hereditary flaw that causes life-threatening amounts of fatty substances in the blood.

In November, a team of scientists led University of California, Los Angeles, announced they had tailored DNA-editing technology to turbocharge how the body fights cancer cells.

These systems are given simple instructions on what the creator wants via text. Tools like DALL-E and Midjourney, for example, can create everything from absurd hypotheticals and porn to realistic faces of fake people and self-portraits in a matter of seconds

They modified patients’ genes to instruct cancer-fighting cells to swarm tumors using CRISPR, administered as a one-off injection.

Then there is the lasted form of CRISPR, ‘CRISPR 3.0,’ which lets scientists insert pieces of DNA into a genome, which could allow them to replace disease-causing genes.

AI that makes images: Systems create stunning images from simple phrases

WHO: OpenAI, Stability AI, Midjourney, Google 

WHEN: Now

OpenAI released its original version of DALL-E, named after Spanish surrealist artist Salvador Dali, and Pixar robot WALL-E, in January 2021.

This system launched as a limited test of ways AI could represent concepts – from boring descriptions to flights of fancy.

And a year later, OpenAi released DALL-E 2, which produces complete images from a simple plain English sentence.

The new version can create images from simple text, add objects to existing images, or even provide different points of view on an existing image. 

MIT Technology Review notes that ‘the biggest game-changer was Stable Diffusion, an open-source text-to-image model released for free by UK-based startup Stability AI in August.

This system also produces stunning images, but is designed to run on a home computer rather than a professional device.

‘By making text-to-image models accessible to all, Stability AI poured fuel on what was already an inferno of creativity and innovation,’ according to MIT Technology Review.

While many might not thing chips are advancing, the standard at which they are made is. The open standard known as RISC-V simplifies instructions given to the processor to accomplish tasks and provides the flexibility to create thousands

‘Millions of people have created tens of millions of images in just a few months. But there are problems, too.’

Google has long been in the AI industry but is making a stronger push to stay relevant. 

The tech giant released AI-generated video clips that looked like human hands made them. 

A chip design that changes everything: New standards will let anyone create chips

WHO: RISC-V International, Intel, SiFive, SemiFive, China RISC-V Industry Alliance

WHEN: Now

Computer chip designs are expensive and hard to license. 

That is all about to change thanks to the popular open standard known as RISC-V, which simplifies the instructions given to the processor to accomplish tasks and provides the flexibility to create thousands of possible custom processors.

This new standard would also speed up the process for companies to get their products to market. 

RISC-V’s simplest design has just 47 instructions. But RISC-V also offers other design norms for companies seeking chips with more complex capabilities.

America has long been the leader in using drones on the battlefield. This is due to its Predator (pictured)  that was conceived in the early 1990s and cost around $40 million

Technologies are advancing to allow other countries to create war drones at a lower cost. For example, Iran produced a $30,000 drone capable of long-range missions that Russia used (pictured) 

‘About 3,100 members worldwide, including companies and academic institutions, are now collaborating via the nonprofit RISC-V International to establish and develop these norms,’ according to MIT Technology Review.

‘In February 2022, Intel announced a $1 billion fund that will, in part, support companies building RISC-V chips.’

Although slowly, these chips are currently being used and are found in earbuds, hard drives and AI processors.

Mass-market military drones: Providing drones at a lower price will change the way wars are fought

WHO: Baykar Technologies, Shahed Aviation Industries

WHEN: Now

America has long been the leader in using drones on the battlefield.

This is due to the nation’s Predator which was conceived in the early 1990s and cost around $40 million.

With the news of the US Supreme Court ruling to overturn Roe v. Wade on June 24, 2022, medical experts set out to provide care to those in states where abortion is now banned  by shipping abortion pills to their homes

One reason for the dominance is that the US has the funds for such technologies.

However, MIT Technology Review notes that the game has changed, and military drones are being produced at a lower price, allowing nations like Ukraine, Iran and Turkey to utilize the weapons.

For example, Iran produced a $30,000 drone capable of long-range missions, while Turkey produced its own for $5 million. 

‘The tactical advantages are clear. What’s also sadly clear is that these weapons will take an increasingly horrible toll on civilian populations around the world,’ reads the report.

Abortion pills via telehealth: A new market emerges after the overturn of Roe v. Wade   

WHO: Choix, Hey Jane, Aid Access, Just the Pill, Abortion on Demand, Planned Parenthood, Plan C

WHEN: Now

Medical treatment was transformed when the coronavirus pandemic gripped the US. 

People could get treatment using a smartphone or computer in the comfort of their homes.

And with the news of the US Supreme Court ruling to overturn Roe v. Wade on June 24, 2022, medical experts set out to provide care to those in states where abortion is now banned. The procedure is illegal in 11 states.

Nonprofits like Aid Access and startups like Choix, Hey Jane and  Just the Pill launched in what like seemed overnight.

Organs on demand is another on MIT’s list. This innovation could save hundreds of thousands of lives.  Terminal heart failure sufferer David Bennett underwent the nine-hour experimental procedure where he received a heart transplant from a genetically-modified pig

In 2019, researchers in Germany created transparent human organs using a new technology that could pave the way to print three-dimensional body parts such as kidneys for transplants

These companies ship abortion pills to people’s homes after they sign up with a photo ID and consult with a medical provider via video call, text or an app, who then prescribes the pills.

 And while abortion is illegal in nearly a dozen states, this month, the Food and Drug Administration (FDA) approved online and brick-and-mortar retail pharmacies to dispense abortion pills to patients who have a prescription – regardless of their location.

Organs on demand: Gene-editing animal organs, 3D printing organs and growing organs in a lab to save human lives

WHO: eGenesis, Makana Therapeutics, United Therapeutics

WHEN: 10 to 15 years 

More than 106,000 people in the US are waiting for an organ transplant, and science is stepping in to create organs to help save lives.

In 2019, researchers in Germany created transparent human organs using a new technology that could pave the way to print three-dimensional body parts such as kidneys for transplants.

Scientists led by Ali Erturk at Ludwig Maximilians University in Munich have developed a technique that uses a solvent to make organs such as the brain and kidneys transparent.

Electric vehicles are here to stay, and Tesla is leading the pack. The world’s roads saw about 16.5 million EVs cruising in 2022, triple the amount in 2018, and global sales were up by 75 percent from the same period in 2022

However, Tesla has competition. MIT notes Hyundai’s IONIQ 5 that was announced last year

Lasers then scan the organ in a microscope that allows researchers to capture the entire structure, including the blood vessels and every single cell in its specific location.

Another method is genetically modifying animal organs, which the world witnessed in January 2022.

Terminal heart failure sufferer David Bennett underwent the nine-hour experimental procedure at the University of Maryland Medical Center in Baltimore, where he received a heart transplant from a genetically-modified pig.

Surgeons used a heart taken from a pig that had undergone gene editing to make it less likely that his body’s immune system would reject the organ. 

The inevitable EV: Electric vehicles have been available for decades. Now they’ve finally become mainstream

WHO: BYD, Hyundai, Tesla, Volkswagen

WHEN: Now 

Electric vehicles have made waves in the automobile industry, as many nations are phasing out gas-powered cars for greener versions.

The world’s roads saw about 16.5 million EVs cruising in 2022, triple the amount in 2018, and global sales were up by 75 percent from the same period in 2022.

The largest player is Elon Musk’s Tesla, which has held most of the market since it sold the first Model S sedan in 2012.

NASA’s James Webb Space Telescope is set to change what we know about the cosmos and is revealing what the early universe looked like. Here is an image of a 13.5-billion-year-old galaxy

However, Tesla has been joined by Volkswagen and Hyundai, among others like Ford, which are planning to overtake Musk’s company.

Herbert Diess, the current chairman of the board of management of Volkswagen Group, said the German company is looking to surpass Tesla by 2025. 

VW sold 452,900 EVs worldwide in 2021, while Tesla sold 930,422. 

Hyundai recently gained popularity with its IONIQ 5 for $72,000, which was named Carsales Car of the Year for 2021.

The IONIQ 5 is the first electric vehicle to win the Carsales prize since the Tesla Model S was named Car of the Year in 2015 and was one of three fully electric cars on the Carsales 2021 shortlist of 12 models. 

James Webb Space Telescope: A marvel of precision engineering that could revolutionize our view of the early universe

WHO: NASA, European Space Agency, Canadian Space Agency, Space Telescope Science Institute

WHEN: Now

The world is also seeing never-before-images of stars forming in deep space

The James Webb Space Telescope, launched December 25, 2021, spent the last year wowing the world with amazing never-before-seen pictures of the cosmos.

Developed by NASA, the $10 billion telescope is a collaboration between the US, Europe and Canada.

Webb is the world’s largest and most powerful orbital space telescope, capable of peering back 100 to 200 million years after the big bang.

The orbiting infrared observatory is designed to be about 100 times more powerful than its predecessor, the Hubble Space Telescope.

NASA likes to think of James Webb as a successor to Hubble rather than a replacement.

Webb has shared images of galaxies that formed 13.5 billion years ago, just 300 million years after the big bang, the first photos of stars formed and recently identified a previously unknown planet.

Ancient DNA analysis: Provides scientists with a time machine to see the past

WHO: Max Planck Institute for Evolutionary Anthropology, David Reich Lab at Harvard 

WHEN: Now

Ancient DNA analysis provides scientists with a trip back in time to learn about early humans. Scientists analyzed DNA from 4,000-year-old mummies found in China and found the individuals were from a local tribe, not visitors from the West as previously believed

 Ernie Lapointe (right) made headlines in 2021 when his DNA matched the famed Native American Sitting Bull (left)

A man made headlines in 2021 when his DNA matched the famed Native American Sitting Bull.

University of Cambridge-led experts demonstrated the technique known as ‘autosomal DNA’ that collected DNA from a strand of hair taken from Sitting Bull and pulled DNA from it. 

The team then matched the DNA with Ernie Lapointe, confirming he is the great-grandson of the Native American leader. 

Going back in time, scientists analyzed DNA from 4,000-year-old mummies found in China and found the individuals were from a local tribe, not visitors from the West as previously believed.

The team compared the mummies’ DNA with samples from five individuals who lived further north in the Dzungarian Basin about 5,000 years ago, making them the oldest known human remains in the region. 

Battery recycling: New ways to recover the crucial metals in batteries could make electric vehicles more affordable

WHO: CATL, Umicore, Redwood Materials, Li-Cycle, Cirba

WHEN: Now 

Battery recycling is seeing a boom as the world moves away from gas-powered vehicles and toward zero-emission versions

Batteries used in electric cars, laptops and other electronics have long been tossed in landfills because there is no method for recycling.

Battery recycling is an effective way of reprocessing and reusing batteries to reduce wastage. 

It prevents the potential threat surfacing from dumping heavy metals and toxic chemicals into the environment. 

In 2022, the market value shot up to $15.81 billion and is predicted to reach a whopping $36 billion in 2028. 

CATL announced a $5 billion battery recycling center in China last year to recycle EV batteries for chemicals such as cobalt and lithium. 

Umicore has a plant in Belgium with an annual capacity of 7,000 lithium-ion batteries and battery production scrap, equivalent to 35,000 EV batteries.

The plant started operations in 2011 to treat portable electronic batteries and the first generations of EV batteries.

The recovered metals will be delivered in battery-grade quality at the end of the Umicore recycling process, allowing them to be re-circulated into the production of new Li-ion batteries.

These facilities are also likely to appear worldwide as nations are adopting EVs to combat climate change, making zero-emission cars cheaper because there would be more materials available.

Read original article here

High blood pressure went up even more early in the pandemic, study finds



CNN
 — 

People in the US with high blood pressure saw their levels rise during the first eight months of the Covid-19 pandemic, a new study says.

When someone has high blood pressure, the force of their blood pushes against the walls of their blood vessels, making their heart less efficient. Both vessels and heart must work harder. Without treatment, high blood pressure will eventually damage the arteries, raising the person’s risk of a heart attack or stroke.

Heart disease is the No. 1 killer in the world, and well-controlled blood pressure is the leading modifiable risk factor, according to the researchers on the new study, published Tuesday in the journal Hypertension.

The US National Institutes of Health, which helped fund the study, said it is one of the most extensive looks at blood pressure trends from the beginning of the pandemic.

The researchers looked at the records of more than 137,000 adults with high blood pressure and compared their levels from August 2018 to January 2020 with their levels from April 2020 through January 2021. The records came from Cedars-Sinai Medical Center in Los Angeles, Columbia University Irving Medical Center in New York City and Ochsner Health in New Orleans. The participants, on average, were 66 years old. More than half were women, and 30% were Black.

Blood pressure is measured in millimeters of mercury (abbreviated as mmHg). The measurement has an upper number, or systolic reading, and a lower number, a diastolic reading.

Systolic pressure measures the force of blood as it pumps out of the heart into the arteries, and diastolic is the pressure created as the heart rests between beats. High blood pressure is defined as a systolic pressure over 140mmHg and a diastolic blood pressure over 90 mmHg.

In the study, the patients’ systolic readings rose 1.79 mmHg, on average, and their diastolic readings went up an average of 1.30 mmHg.

“Although these increases appear small, studies show that just a 2 mmHg increase in blood pressure can raise the risk of major cardiovascular events by as much as 5%,” the NIH said in a news release.

The overall rise in numbers was “smaller than expected,” said study author Dr. Hiroshi Gotanda, an assistant professor in the division of General Internal Medicine at Cedars-Sinai Medical Center.

Gotanda thinks the expansion of telemedicine during the pandemic may have helped. Other studies have found that telemedicine is an effective alternative to an in-person doctor visit to manage high blood pressure.

Because high blood pressure doesn’t always cause symptoms, people who have it are encouraged to monitor their numbers at home. If they have a doctor’s appointment, they may be more mindful about keeping track so they have something to report. And during an appointment, doctors can change their prescription if their blood pressure is consistently high.

In the first three months of the pandemic, the study found, people weren’t checking their blood pressure at home as much as they had been. Measurements declined as much as 90% from before the pandemic. The number of checks went up over time, but even at the end of the study period, the measurements were still below pre-pandemic levels.

The study had some limitations, including that it measured only people who were able to access health care. Those without health care or insurance may have had a different result.

“The impact of the pandemic on their blood pressure might have been much larger,” Gotanda said.

The study doesn’t suggest why blood pressure levels went up, and it’s hard to tell on an individual basis, Gotanda said. But it may involve pandemic-related changes in routines.

Dr. Eduardo Sanchez, the American Heart Association’s chief medical officer for prevention, offered some other reasons: “Clinical care visits declined dramatically in the early months of the pandemic – delayed care seeking by patients and reduced access by some clinical care providers. Patient behavior was driven by their interpretation of COVID prevention messages and fear of COVID. Early on, job loss may have contributed to less care and not filling prescriptions. Visits have been increasing and blood pressure control is increasing but lagging.”

Additionally, studies show that people have gotten less sleep – and less quality sleep – during the pandemic. With gyms closed and people staying home more, they exercised less, had less-healthy diets and drank more alcohol.

Gotanda said the researchers hope to look next at what impact even this slight blood pressure increase will have on a patient’s overall heath. They also want to know which of the patients may have had a hard time accessing telemedicine.

Telemedicine could have a broad impact. Nearly half of adults in the United States have high blood pressure, according to the US Centers for Disease Control and Prevention, and about half of those have what doctors consider uncontrolled high blood pressure. That’s about 37 million adults – and with the ongoing obesity epidemic, the number will probably grow.

High blood pressure can be genetic, but there are things you can do to keep it in check. Keeping a close eye on your numbers is the first step, the American Heart Association recommends. People who know their numbers can make changes if they need.

Medication can treat high blood pressure, and lifestyle changes could help, like stopping smoking or vaping, managing stress, keeping a healthy weight and eating a heart-healthy diet.

A heart-healthy diet is high in vegetables, whole grains and low-fat dairy, and low in salt, saturated fat, red meat and sweets. It’s also one that keeps alcohol to a minimum. The American Heart Association suggests no more than two drinks per day for men, one for women.

Read original article here

Ivermectin frenzy: the advocates, anti-vaxxers and telehealth companies driving demand | Coronavirus

At the top of a Florida-based telehealth website that promises “quality meds with fast shipping”, above a menu of skin care products, erectile dysfunction medications and hair loss treatments, sits a bright orange banner with bold lettering: “LOOKING FOR IVERMECTIN? CLICK HERE,” it reads.

The telehealth site is one of numerous online providers that have moved to capitalize on the surge in demand for ivermectin as Covid-19 cases rise across the US. The drug, an anti-parasitic used in both humans and livestock, has become the latest in a series of much-hyped medications for which doctors say there is no conclusive evidence they work to treat coronavirus.

Driving the ivermectin frenzy is a cottage industry of advocacy groups, anti-vaccine activists and telehealth companies. Touting the drug as a “miracle cure” for Covid-19, these groups have rapidly risen to prominence, finding a fervent audience among conservative media figures, the vaccine-hesitant and people desperate to treat loved ones suffering from the virus.

The Centers for Disease Control and Prevention (CDC), as well as the Food and Drug Administration (FDA), put out advisories in August warning against using ivermectin for Covid-19. The February guidelines from the National Institutes of Health (NIH) state there is not enough evidence “either for or against” recommending the drug.

Still, medical advocacy groups and anti-vaccine activists have heavily promoted ivermectin online and in the media as the key to ending the pandemic and have shared lists of doctors and companies that will offer it – sometimes directing those interested to dubious medical providers. The hype has caused runs on pharmacies, with reports of people resorting to eating versions of the drug intended for horses when they can’t get their hands on its formulation for humans.

‘The solution to Covid-19’

Ivermectin has a widespread use treating parasitic diseases when formulated for humans – a discovery that won the 2015 Nobel prize in medicine. The drug is used for Covid-19 in Latin American nations as well as several European countries. But experts say there is no proven record of its effectiveness against viruses, and multiple studies have cast doubt on its uses in treating Covid-19.

“There’s really no compelling evidence it works,” said Dr Peter Hotez, a professor and dean of the National School of Tropical Medicine at Baylor College of Medicine who previously worked on health policy for using vermectin to treat parasitic diseases.

Medical experts have also found problems with the studies that ivermectin advocates praise. One medical journal retracted a much vaunted pro-ivermectin study after doctors raised serious concerns over plagiarism and data manipulation. A review of existing studies into the drug from an international organization that reviews medical research found a lack of reliable evidence to support the drug’s use for treatment or prevention of Covid-19 outside of clinical trials and criticized the quality of studies that do exist on ivermectin. A more rigorous, large clinical trial from the University of Oxford is currently underway to see if the drug could have any benefit.

Despite outstanding questions over ivermectin’s efficacy, several advocacy organizations have been on a nearly year-long campaign to mainstream the drug. Two of the most prominent groups backing ivermectin as a Covid-19 treatment are the UK-based British Ivermectin Recommendation Development (Bird) and the US-based Front Line Covid-19 Critical Care Alliance (FLCCC).

The FLCCC started as a nonprofit network of doctors attempting to establish protocols for Covid-19 patient care in the initial days of the pandemic. The group became an early advocate for the use of steroids in treatment, and in late 2020 shifted its focus to ivermectin, arguing the drug was a low cost option that could both treat and prevent the virus while vaccines were not widely available.

Bird, a nonprofit group of doctors in the UK, took on a similar advocacy role. Its members published analyses promoting the drug, and the group started a now-defunct GoFundMe to “help us get life-saving drug approved for Covid-19”. The fund had raised around $44,000 as of last month. The FLCCC also solicits donations on its website, and in July it received a $100,000 award from a Malaysian charitable trust.

Doctors in both groups have been on a media blitz during the last year, publishing protocols and promotional material on ivermectin, giving interviews to news outlets, holding panels and appearing on podcasts.

But other doctors have cautioned the groups have relied on weak data, ignored studies that show ivermectin is not effective and made numerous misleading claims in their push for the drug – such as FLCCC tweeting last month that “this could all be over by the end of August” and one founding member comparing restrictions on ivermectin to genocide.

Bird founder Tess Lawrie told the Guardian that Bird is a crowd-funded initiative aimed at getting ivermectin approved for Covid-19, and that it stands by its claims that the drug could end the pandemic in weeks if used for prevention and treatment.

The FLCCC did not respond to the Guardian’s request for comment.

Both the FLCCC and Bird have drawn further scrutiny from other medical professionals for affiliating with prominent anti-vaccine organizations. In September, the FLCCC and Bird sent open letters to health departments in Australia, New Zealand, Iceland and the Cayman Islands advocating for the use of ivermectin for a variety of Covid-19 treatments. Listed as partner organizations on the letters were several international anti-vaccine groups, including the organization of prolific anti-vaxxer Robert F Kennedy Jr.

Robert F Kennedy Jr speaks during a protest against coronavirus-related restrictions in Berlin on 29 August 2020. Photograph: Sean Gallup/Getty Images

“For an organization that is not anti-vaxx it seems to be incredibly comfortable co-promoting organizations that are anti-vaxx,” said Dr Kyle Sheldrick, a Sydney-based doctor who has raised alarm over unethical conduct in pro-ivermectin studies. “As a doctor myself, I would not be part of any group that keeps the sort of company that FLCCC keeps.”

Co-founder and president of FLCCC, pulmonary care specialist Dr Pierre Kory, has also found allies among influential politicians and media figures who have spoken critically of Covid-19 vaccines.

At a December 2020 hearing chaired by Senator Ron Johnson, who has falsely claimed that natural immunity is better than vaccine immunity and made misleading statements about vaccinations causing death, Kory called ivermectin “the solution to Covid-19”. The appearance boosted Kory’s online following and led to appearances on several popular podcasts that have questioned vaccinations. In June, Kory was a guest on Joe Rogan’s top-rated podcast, telling Rogan’s millions of listeners that his “dream is that every household has ivermectin in the cupboard” while suggesting that technology companies were censoring discussion of the drug.

Pierre Kory did not respond to the Guardian’s request for comment.

Lawrie, the Bird founder, told the Guardian the group considers its affiliates’ stance on vaccination “irrelevant to the global need for early safe and effective treatment for Covid-19”.

A conservative rallying point

Public interest in ivermectin ballooned following Joe Rogan’s podcasts. “On a national level Rogan’s podcast was a tipping point,” said Keenan Chen, an investigative researcher with First Draft News, an organization that tracks misinformation. (Rogan, who has previously expressed hesitancy to vaccines, announced in September he had contracted Covid-19. He claimed to be taking ivermectin among several other treatments.)

As interest in ivermectin spread, opinions on the drug became subsumed into a broader culture war. As health authorities dismissed it, some advocates increasingly claimed that there was a wide-ranging conspiracy against the drug, accusing tech platforms and big pharma of censorship. Some FLCCC members appeared in YouTube videos promoting conspiracy theories, with titles such as “Exposed! FDA, CDC & WHO is hiding this from you?” In one video, the hosts claimed, “There is a conspiracy to block and ban discussion of treatments that will not make any money for the big pharmaceutical companies.”

Fox News hosts, including Tucker Carlson and Laura Ingraham, featured guests promoting the drug and deriding public health officials for cautioning against its use. Conservative radio hosts joined in recommending the drug, including one host who has since died of Covid-19.

Joe Rogan, who previously expressed doubt about vaccines, announced in September he had contracted Covid-19. Photograph: Syfy/NBCU Photo Bank/NBCUniversal/Getty Images

As ivermectin turned into a conservative rallying point, some groups began to take advantage of its new audience. At least three telehealth sites offering ivermectin have ties to America’s Frontline Doctors, a rightwing political group that went viral in July 2020 after far-right media outlet Breitbart shared video of a press conference in which members falsely claimed unproven treatments as cures for Covid-19 and stated people did not need to wear masks.

Donald Trump, his son Donald Trump Jr and numerous QAnon conspiracists shared the video, and within hours it was viewed millions of times before social media platforms removed it for violating public health policies. The group’s founder, Simone Gold, is facing charges for taking part in the 6 January riot at the Capitol. AFD recently promoted ivermectin to its more than 170,000 subscribers on Telegram.

The telehealth site MyFreeDoctor, which heavily promotes pro-ivermectin sources on its website, is founded by AFD member Ben Marble and employs many members of the group. Another site, SpeakWithAnMD, is frequently mentioned on pro-ivermectin social media channels and works in partnership with America’s Frontline Doctors. It charges $90 for consultations.

Dr Stella Immanuel, another member of America’s Frontline Doctors, posted on her medical practice Facebook page this month that “we went from 100 to 700+ a day signing up for telehealth in three weeks” and are “totally swamped” with patients seeking ivermectin.

Immanuel became infamous last year as a high-profile promoter of hydroxychloroquine, an anti-malaria drug that the FDA warns is not safe or effective against Covid-19 but which became a rightwing rallying point, as well as for her claims that common illnesses were the result of people having sex with demons in their dreams and that “reptilians” run the government. Her consultation fee is also $90.

Stella Immanuel, Ben Marble and America’s Frontline Doctors did not return requests for comment.

A potentially dangerous distraction

As advocacy groups and conservative media promoted ivermectin in recent months, their message has found an eager audience online. On Telegram and other messaging platforms, pro-ivermectin communities have become hubs for anti-vaccine misinformation, with members sharing tips for pharmacies and telehealth providers who will order them the drug. In pro-ivermectin Facebook groups, members have promoted the drug’s use, condemned its opponents and discussed taking legal action against doctors who won’t administer it.

“These doctors are misleading the people. Ivermectin works,” one user commented in a private ivermectin Facebook group with over 28,000 members. “Make sure you get IVM now already before you need it. Your family’s health depends on it,” another user posted.

“Just got into a fight with my mother this morning bc she said that they’re no reliable peer reviewed studies showing the benefit and that WHO warns against it,” one member complained, only to be reassured of their beliefs by others in the group.

Facebook has stated that it will enforce violations of its policies on Covid-19 information and vaccines, which includes prohibiting claims that ivermectin is a guaranteed cure or ads for the drug. “We remove content that attempts to buy, sell, or donate for ivermectin,” a spokesperson told the Guardian. “We don’t allow ads promoting ivermectin as a treatment for Covid-19.”

Several health authorities have issued a joint statement strongly opposing ivermectin prescription, ordering and distribution outside clinical trials. Photograph: Soumyabrata Roy/NurPhoto/REX/Shutterstock

The hype over ivermectin caused the CDC to last month report a 24-fold increase in US prescriptions compared with pre-pandemic levels. Livestock suppliers, who carry a non-prescription version of the drug formulated for use on horses and other animals, say they are facing unprecedented demand. Poison control centers in multiple states have received a spike in calls from people taking ivermectin not intended for human consumption, including Mississippi reporting last month that at least 2% of its recent calls were due to the drug. (The FLCCC has, for its part, put out statements directing people not to take the version of ivermectin intended for livestock, but blamed health authorities for the confusion.)

The American Medical Association, American Pharmacists Association and American Society of Health-System Pharmacists have issued a joint statement strongly opposing ivermectin prescription, ordering and distribution outside clinical trials.

Barring new data that proves ivermectin’s efficacy in treating Covid-19, many health experts view the drug as a potentially dangerous distraction.

“There are lots of promising treatments that are much farther along the research and development pipeline than ivermectin,” said Dr Jorge Caballero, co-founder of Coders against Covid, an organization that analyzes Covid data. “Let’s focus on the library of things that we do know work. We know that vaccines work.”

But despite health warnings and scant evidence that ivermectin is the miracle cure that its adherents want it to be, the idea of a quick and easy solution to the pandemic has proven to have enduring appeal.

“It’s much easier to come along and sell a message where the answer is simple: there is a cure, it’s what you wanted to believe anyway and the power is in your hands,” said Sheldrick. “It actually doesn’t matter how poor the evidence base is. If that is your message, you will find an audience.

This article was amended on 13 September 2021. An earlier version said that 70% of calls to poison centers in Mississippi concerned ivermectin. The state’s department of health originally gave that figure to the Associated Press; AP and the health department later corrected this to 2%.

Read original article here